NEW YORK (GenomeWeb News) - Thomson Reuters said today that the National Cancer Institute will use the company’s BiomarkerCenter database to support its research on potential cancer therapeutics.
 
Thomson Reuters said that NCI’s Developmental Therapeutics program and its associated Biomarker Program will use BiomarkerCenter, a database of information on biomarkers that alerts uses to status changes of biomarkers of interest. The company launched the database in June.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.